KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strategy (MSTR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Strategy (MSTR) over the last 17 years, with Q3 2025 value amounting to $54.3 million.

  • Strategy's Cash & Equivalents rose 1713.74% to $54.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.3 million, marking a year-over-year increase of 1713.74%. This contributed to the annual value of $38.1 million for FY2024, which is 1858.3% down from last year.
  • As of Q3 2025, Strategy's Cash & Equivalents stood at $54.3 million, which was up 1713.74% from $50.1 million recorded in Q2 2025.
  • Strategy's 5-year Cash & Equivalents high stood at $94.3 million for Q1 2023, and its period low was $38.1 million during Q4 2024.
  • For the 5-year period, Strategy's Cash & Equivalents averaged around $61.8 million, with its median value being $60.3 million (2025).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first crashed by 8660.03% in 2021, then surged by 2302.7% in 2022.
  • Strategy's Cash & Equivalents (Quarter) stood at $63.4 million in 2021, then crashed by 30.81% to $43.8 million in 2022, then grew by 6.8% to $46.8 million in 2023, then fell by 18.58% to $38.1 million in 2024, then soared by 42.42% to $54.3 million in 2025.
  • Its Cash & Equivalents was $54.3 million in Q3 2025, compared to $50.1 million in Q2 2025 and $60.3 million in Q1 2025.